Study of the Saftey of TTX-030 as a single agent and in Combination with Pembrolizumab or Chemotherapy in Patients with Lymphoma or Solid Tumor Malignancies (TTX-030-001)
Study of the Saftey of TTX-030 as a single agent and in Combination with Pembrolizumab or Chemotherapy in Patients with Lymphoma or Solid Tumor Malignancies (TTX-030-001)
Trial Category:
Lymphoma
Phase
I
Contact(s)
Location(s)
Nebraska Cancer Specialists, Omaha, NE
